Report overview
This report contains market size and forecasts of Coagulation Factor Concentrates in global, including the following market information:
Global Coagulation Factor Concentrates Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Coagulation Factor Concentrates Market Sales, 2017-2022, 2023-2028, (K Pcs)
Global top five Coagulation Factor Concentrates companies in 2021 (%)
The global Coagulation Factor Concentrates market was valued at 6648.2 million in 2021 and is projected to reach US$ 9852.3 million by 2028, at a CAGR of 5.8% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Factor VIII Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Coagulation Factor Concentrates include CSL (Australia), Grifols (Spain), Shire (Ireland), Octapharma (Switzerland), Kedrion (Italy), Bio Product Laboratory (UK), Sanquin (Netherlands), LFB (France) and Biotest (Germany), etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Coagulation Factor Concentrates manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Coagulation Factor Concentrates Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Coagulation Factor Concentrates Market Segment Percentages, by Type, 2021 (%)
Factor VIII
Factor IX
Von Willebrand Factor
Prothrombin Complex Concentrates
Fibrinogen Concentrates
Factor XIII
Global Coagulation Factor Concentrates Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Coagulation Factor Concentrates Market Segment Percentages, by Application, 2021 (%)
Neurology
Immunology
Hematology
Critical Care
Pulmonology
Hemato-Oncology
Rheumatology
Others
Global Coagulation Factor Concentrates Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Coagulation Factor Concentrates Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Coagulation Factor Concentrates revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Coagulation Factor Concentrates revenues share in global market, 2021 (%)
Key companies Coagulation Factor Concentrates sales in global market, 2017-2022 (Estimated), (K Pcs)
Key companies Coagulation Factor Concentrates sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
CSL (Australia)
Grifols (Spain)
Shire (Ireland)
Octapharma (Switzerland)
Kedrion (Italy)
Bio Product Laboratory (UK)
Sanquin (Netherlands)
LFB (France)
Biotest (Germany)
Japan Blood Products Organization, China Biologic Products (China)
Green Cross Corporation (South Korea)
Shanghai RAAS Blood Products (China)
